(RWAY) Runway Growth Finance - Ratings and Ratios
Senior-Secured Loans, Growth-Stage Lending
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 13.96% |
| Yield on Cost 5y | 18.87% |
| Yield CAGR 5y | 3.57% |
| Payout Consistency | 93.7% |
| Payout Ratio | 82.8% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 21.7% |
| Value at Risk 5%th | 33.4% |
| Relative Tail Risk | -6.19% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.30 |
| Alpha | -15.94 |
| CAGR/Max DD | 0.13 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.402 |
| Beta | 0.602 |
| Beta Downside | 0.788 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.13% |
| Mean DD | 9.04% |
| Median DD | 9.29% |
Description: RWAY Runway Growth Finance December 28, 2025
Runway Growth Finance Corp. (NASDAQ:RWAY) is a Business Development Company (BDC) that provides senior-secured loans to late-stage and growth-phase companies, typically ranging from $10 million to $75 million per transaction.
The firm concentrates on sectors with high-margin, recurring-revenue models, including technology (systems software, hardware, storage, and internet services), life sciences and healthcare (biotech, medical devices, and health-tech platforms), and business-service niches such as data processing, outsourced services, and human-resources outsourcing.
As of the most recent filing, RWAY reported assets under management of roughly $1.1 billion, a portfolio weighted ~70 % toward technology-related loans, and a net asset value (NAV) per share of $12.45, reflecting a dividend yield near 8 %-both metrics that are sensitive to interest-rate cycles and credit-quality trends in the high-growth loan market. For deeper metrics, check ValueRay’s dashboard.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 54.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 0.40 > 1.0 |
| NWC/Revenue: -13.49% < 20% (prev 0.51%; Δ -14.00% < -1%) |
| CFO/TA 0.04 > 3% & CFO 42.3m > Net Income 54.9m |
| Net Debt (435.6m) to EBITDA (54.9m): 7.93 < 3 |
| Current Ratio: 0.53 > 1.5 & < 3 |
| Outstanding Shares: last quarter (36.2m) vs 12m ago -5.64% < -2% |
| Gross Margin: 64.10% > 18% (prev 0.59%; Δ 6351 % > 0.5%) |
| Asset Turnover: 10.44% > 50% (prev 8.46%; Δ 1.98% > 0%) |
| Interest Coverage Ratio: -0.99 > 6 (EBITDA TTM 54.9m / Interest Expense TTM 38.2m) |
Altman Z'' -0.66
| A: -0.01 (Total Current Assets 16.0m - Total Current Liabilities 30.3m) / Total Assets 963.3m |
| B: -0.06 (Retained Earnings -56.3m / Total Assets 963.3m) |
| C: -0.04 (EBIT TTM -37.9m / Avg Total Assets 1.02b) |
| D: -0.12 (Book Value of Equity -56.0m / Total Liabilities 473.8m) |
| Altman-Z'' Score: -0.66 = B |
Beneish M
| DSRI: 1.22 (Receivables 8.04m/5.65m, Revenue 106.4m/91.0m) |
| GMI: 0.92 (GM 64.10% / 58.97%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.17 (Revenue 106.4m / 91.0m) |
| TATA: 0.01 (NI 54.9m - CFO 42.3m) / TA 963.3m) |
| Beneish M-Score: cannot calculate (missing components) |
ValueRay F-Score (Strict, 0-100) 52.52
| 1. Piotroski: 4.0pt |
| 2. FCF Yield: 5.46% |
| 3. FCF Margin: 39.80% |
| 4. Debt/Equity: 0.91 |
| 5. Debt/Ebitda: 7.93 |
| 6. ROIC - WACC: -7.45% |
| 7. RoE: 10.94% |
| 8. Revenue Trend: 43.94% |
| 9. EPS Trend: -24.25% |
What is the price of RWAY shares?
Over the past week, the price has changed by -0.53%, over one month by +6.50%, over three months by -3.27% and over the past year by -6.04%.
Is RWAY a buy, sell or hold?
- Strong Buy: 3
- Buy: 0
- Hold: 6
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the RWAY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 10.8 | 15.4% |
| Analysts Target Price | 10.8 | 15.4% |
| ValueRay Target Price | 10.9 | 17% |
RWAY Fundamental Data Overview January 19, 2026
P/E Forward = 6.3251
P/S = 2.4052
P/B = 0.6931
P/EG = 1.1571
Revenue TTM = 106.4m USD
EBIT TTM = -37.9m USD
EBITDA TTM = 54.9m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 443.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 435.6m USD (from netDebt column, last quarter)
Enterprise Value = 774.9m USD (339.3m + Debt 443.5m - CCE 7.92m)
Interest Coverage Ratio = -0.99 (Ebit TTM -37.9m / Interest Expense TTM 38.2m)
EV/FCF = 18.30x (Enterprise Value 774.9m / FCF TTM 42.3m)
FCF Yield = 5.46% (FCF TTM 42.3m / Enterprise Value 774.9m)
FCF Margin = 39.80% (FCF TTM 42.3m / Revenue TTM 106.4m)
Net Margin = 51.60% (Net Income TTM 54.9m / Revenue TTM 106.4m)
Gross Margin = 64.10% ((Revenue TTM 106.4m - Cost of Revenue TTM 38.2m) / Revenue TTM)
Gross Margin QoQ = 55.47% (prev 67.10%)
Tobins Q-Ratio = 0.80 (Enterprise Value 774.9m / Total Assets 963.3m)
Interest Expense / Debt = 2.11% (Interest Expense 9.35m / Debt 443.5m)
Taxrate = 21.0% (US default 21%)
NOPAT = -29.9m (EBIT -37.9m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.53 (Total Current Assets 16.0m / Total Current Liabilities 30.3m)
Debt / Equity = 0.91 (Debt 443.5m / totalStockholderEquity, last quarter 489.5m)
Debt / EBITDA = 7.93 (Net Debt 435.6m / EBITDA 54.9m)
Debt / FCF = 10.29 (Net Debt 435.6m / FCF TTM 42.3m)
Total Stockholder Equity = 501.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.39% (Net Income 54.9m / Total Assets 963.3m)
RoE = 10.94% (Net Income TTM 54.9m / Total Stockholder Equity 501.6m)
RoCE = -4.06% (EBIT -37.9m / Capital Employed (Total Assets 963.3m - Current Liab 30.3m))
RoIC = -2.99% (negative operating profit) (NOPAT -29.9m / Invested Capital 1.00b)
WACC = 4.47% (E(339.3m)/V(782.8m) * Re(8.13%) + D(443.5m)/V(782.8m) * Rd(2.11%) * (1-Tc(0.21)))
Discount Rate = 8.13% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -5.43%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈42.6m ; Y1≈28.0m ; Y5≈12.8m
Fair Price DCF = N/A (negative equity: EV 406.5m - Net Debt 435.6m = -29.1m; debt exceeds intrinsic value)
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -24.25 | EPS CAGR: -42.68% | SUE: -4.0 | # QB: 0
Revenue Correlation: 43.94 | Revenue CAGR: 0.14% | SUE: -0.66 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.36 | Chg30d=-0.003 | Revisions Net=+0 | Analysts=9
EPS next Year (2026-12-31): EPS=1.52 | Chg30d=-0.004 | Revisions Net=+0 | Growth EPS=-4.2% | Growth Revenue=-2.5%
Additional Sources for RWAY Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle